These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Interplay between alternatively spliced Tissue Factor and full length Tissue Factor in modulating coagulant activity of endothelial cells. Ünlü B; Bogdanov VY; Versteeg HH Thromb Res; 2017 Aug; 156():1-7. PubMed ID: 28570958 [TBL] [Abstract][Full Text] [Related]
5. Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression. Kocatürk B; Tieken C; Vreeken D; Ünlü B; Engels CC; de Kruijf EM; Kuppen PJ; Reitsma PH; Bogdanov VY; Versteeg HH J Thromb Haemost; 2015 Sep; 13(9):1683-93. PubMed ID: 26179105 [TBL] [Abstract][Full Text] [Related]
6. Expression of flTF and asTF splice variants in various cell strains and tissues. Pan L; Yu Y; Yu M; Yao S; Mu Q; Luo G; Xu N Mol Med Rep; 2019 Mar; 19(3):2077-2086. PubMed ID: 30664196 [TBL] [Abstract][Full Text] [Related]
7. Alternatively spliced tissue factor is not sufficient for embryonic development. Sluka SH; Akhmedov A; Vogel J; Unruh D; Bogdanov VY; Camici GG; Lüscher TF; Ruf W; Tanner FC PLoS One; 2014; 9(5):e97793. PubMed ID: 24879059 [TBL] [Abstract][Full Text] [Related]
8. Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner. Kocatürk B; Van den Berg YW; Tieken C; Mieog JS; de Kruijf EM; Engels CC; van der Ent MA; Kuppen PJ; Van de Velde CJ; Ruf W; Reitsma PH; Osanto S; Liefers GJ; Bogdanov VY; Versteeg HH Proc Natl Acad Sci U S A; 2013 Jul; 110(28):11517-22. PubMed ID: 23801760 [TBL] [Abstract][Full Text] [Related]
9. Role of the phosphatidylinositol 3-kinase/protein kinase B pathway in regulating alternative splicing of tissue factor mRNA in human endothelial cells. Eisenreich A; Malz R; Pepke W; Ayral Y; Poller W; Schultheiss HP; Rauch U Circ J; 2009 Sep; 73(9):1746-52. PubMed ID: 19597299 [TBL] [Abstract][Full Text] [Related]
10. Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes. Witkowski M; Witkowski M; Saffarzadeh M; Friebel J; Tabaraie T; Ta Bao L; Chakraborty A; Dörner A; Stratmann B; Tschoepe D; Winter SJ; Krueger A; Ruf W; Landmesser U; Rauch U Cardiovasc Diabetol; 2020 Feb; 19(1):20. PubMed ID: 32066445 [TBL] [Abstract][Full Text] [Related]
11. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells. Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171 [TBL] [Abstract][Full Text] [Related]
12. Alternatively spliced tissue factor. A crippled protein in coagulation or a key player in non-haemostatic processes? van den Berg YW; Versteeg HH Hamostaseologie; 2010 Aug; 30(3):144-9. PubMed ID: 20680231 [TBL] [Abstract][Full Text] [Related]
13. Alternatively spliced tissue factor induces angiogenesis through integrin ligation. van den Berg YW; van den Hengel LG; Myers HR; Ayachi O; Jordanova E; Ruf W; Spek CA; Reitsma PH; Bogdanov VY; Versteeg HH Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19497-502. PubMed ID: 19875693 [TBL] [Abstract][Full Text] [Related]
14. Splice variants of tissue factor promote monocyte-endothelial interactions by triggering the expression of cell adhesion molecules via integrin-mediated signaling. Srinivasan R; Ozhegov E; van den Berg YW; Aronow BJ; Franco RS; Palascak MB; Fallon JT; Ruf W; Versteeg HH; Bogdanov VY J Thromb Haemost; 2011 Oct; 9(10):2087-96. PubMed ID: 21812913 [TBL] [Abstract][Full Text] [Related]
15. Regulation and differential role of the tissue factor isoforms in cardiovascular biology. Eisenreich A; Rauch U Trends Cardiovasc Med; 2010 Aug; 20(6):199-203. PubMed ID: 22137642 [TBL] [Abstract][Full Text] [Related]
16. Akt protects mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis through NK-kappa B activation. Hatano E; Brenner DA Am J Physiol Gastrointest Liver Physiol; 2001 Dec; 281(6):G1357-68. PubMed ID: 11705740 [TBL] [Abstract][Full Text] [Related]
17. Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro. Antoniak S; Boltzen U; Eisenreich A; Stellbaum C; Poller W; Schultheiss HP; Rauch U J Thromb Haemost; 2009 May; 7(5):871-8. PubMed ID: 19228282 [TBL] [Abstract][Full Text] [Related]
18. Effect of NF-kappa B Inhibition on TNF-alpha-induced apoptosis and downstream pathways in cardiomyocytes. Bergmann MW; Loser P; Dietz R; von Harsdorf R J Mol Cell Cardiol; 2001 Jun; 33(6):1223-32. PubMed ID: 11444925 [TBL] [Abstract][Full Text] [Related]
19. Simvastatin induces apoptosis in human breast cancer cells in a NFkappaB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa. Aberg M; Wickström M; Siegbahn A Thromb Res; 2008; 122(2):191-202. PubMed ID: 18031796 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of nuclear factor kappaB and phosphatidylinositol 3-kinase/Akt is essential for massive hepatocyte apoptosis induced by tumor necrosis factor alpha in mice. Imose M; Nagaki M; Naiki T; Osawa Y; Brenner DA; Asano T; Hayashi H; Kato T; Moriwaki H Liver Int; 2003 Oct; 23(5):386-96. PubMed ID: 14708901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]